Thalidomide attenuates airway hyperresponsiveness and eosinophilic inflammation in a murine model of allergic asthma

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 6, 2010, Pages 1028-1032

  Asano, Toshiaki ^a   Kume, Hiroaki ^a,b   Taki, Fumitaka ^a,c   Ito, Satoru ^a   Hasegawa, Yoshinori ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Department of Clinical Laboratory   (Japan)

Author keywords

Airway hyperresponsiveness; Asthma; Cytokine; Eosinophilic infiltration; Ovalbumin; Thalidomide

Indexed keywords

INTERLEUKIN 5; METHACHOLINE; OVALBUMIN; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL HYPERPLASIA; CELL INFILTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; GOBLET CELL; HISTOPATHOLOGY; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY CELL; LUNG LAVAGE; MOUSE; NONHUMAN; SENSITIZATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; GOBLET CELLS; HYPERPLASIA; INFLAMMATION; INTERLEUKIN-5; LUNG; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; OVALBUMIN; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953473380     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1028     Document Type: Article

References (35)

1. Busse W. W., Lemanske R. F. Jr., N. Engl. J. Med., 344, 350-362 (2001).
2. Homer R. J., Elias J. A., Physiology, 20, 28-35 (2005).
3. Franks M. E., Macpherson G. R., Figg W. D., Lancet, 363, 1802- 1811 (2004).
4. Ueyama J., Nadai M., Zhao Y. L., Kanazawa H., Takagi K., Kondo T., Takagi K., Wakusawa S., Abe F., Saito H., Miyamoto K., Hasegawa T., Biol. Pharm. Bull., 31, 1596-1600 (2008).
5. Calabrese L., Fleischer A. B., Am. J. Med., 108, 487-195 (2000).
6. Kamikawa R., Ikawa K., Morikawa N., Asaoku H., Iwato K., Sasaki A., Biol. Pharm. Bull., 29, 2331-2334 (2006).
7. Hashimoto Y., Arch. Pharm., 341, 536-547 (2008).
8. Teo S. K., Stirling D. I., Zeldis J. B., Drug Discov. Today, 10, 107- 114 (2005).
9. Chen K. M., Lai S. C., J. Antimicrob. Chemother., 59, 264-276 (2007).
10. Taki F., Kume H., Kobayashi T., Ohta H., Aratake H., Shimokata K., Clin. Exp. Allergy, 37, 599-607 (2007).
11. Farese J. P., Fox L. E., Detrisac C. J., Van Gilder J. M., Roberts S. L., Baldwin J. M., Am. J. Vet. Res., 65, 659-664 (2004).
12. Kobayashi H., Yagyu T., Kondo T., Kurita N., Inagaki K., Haruta S., Kawaguchi R., Kitanaka T., Sakamoto Y., Yamada Y., Kanayama N., Terao T., Cancer Res., 65, 10464-10471 (2005).
13. Sur S., Wild J. S., Choudhury B. K., Sur N., Alam R., Klinman D. M., J. Immunol., 162, 6284-6293 (1999).
14. Mckay A., Leung B. P., Mcinnes I. B., Thomson N. C., Liew F. Y., J. Immunol., 172, 2903-2908 (2004).
15. Tanaka H., Masuda T., Tokuoka S., Komai M., Nagao K., Takahashi Y., Nagai H., Inflamm. Res., 50, 616-624 (2001).
16. Duan W., Chan J. H., Wong C. H., Leung B. P., Wong W. S., J. Immunol., 172, 7053-7059 (2004).
17. Holgate S. T., Polosa R., Nat. Rev. Immunol., 8, 218-230 (2008).
18. Yasui K., Kobayashi N., Yamazaki T., Agematsu K., Curr. Pharm. Des., 11, 395-401 (2005).
19. Kouro T., Takatsu K., Int. Immunol., 21, 1303-1309 (2009).
20. Barnes P. J., Int. J. Biochem. Cell Biol., 29, 867-870 (1997).
21. Keifer J. A., Guttridge D. C., Ashburner B. P., Baldwin A. S. Jr., J. Biol. Chem., 276, 22382-22387 (2001).
22. Noman A. S., Koide N., Khuda Ii, Dagvadorj J., Tumurkhuu G., Naiki Y., Komatsu T., Yoshida T., Yokochi T., Biochem. Biophys. Res. Com-mun., 374, 683-687 (2008).
23. Corral L. G., Kaplan G., Ann. Rheum. Dis., 58 (Suppl. 1), I107-I113(1999).
24. Verbon A., Juffermans N. P., Speelman P., Van Deventer S. J., Ten Berge I. J., Guchelaar H. J., Van Der Poll T., Antimicrob. Agents Chemother., 44, 2286-2290 (2000).
25. Wakahara K., Tanaka H., Takahashi G., Tamari M., Nasu R., Toyohara T., Takano H., Saito S., Inagaki N., Shimokata K., Nagai H., Eur. J. Pharmacol., 578, 87-96 (2008).
26. Barrett N. A., Austen K. F., Immunity, 31, 425-437 (2009).
27. Thomas P. S., Immunol. Cell Biol., 79, 132-140 (2001).
28. Gagliardo R., Chanez P., Mathieu M., Bruno A., Costanzo G., Gougat C., Vachier I., Bousquet J., Bonsignore G., Vignola A. M., Am. J. Respir. Crit. Care Med., 168, 1190-1198 (2003).
29. Hart L. A., Krishnan V. L., Adcock I. M., Barnes P. J., Chung K. F., Am. J. Respir. Crit. Care Med., 158, 1585-1592 (1998).
30. Cockcroft D. W., Davis B. E., J. Allergy Clin. Immunol., 118, 551- 559 (2006).
31. Hamelmann E., Gelfand E. W., Int. Arch. Allergy Immunol., 120, 8-16 (1999).
32. Nakae S., Lunderius C., Ho L. H., Schafer B., Tsai M., Galli S. J., J. Allergy Clin. Immunol., 119, 680-686 (2007).
33. Rodrigues G. B., Passos G. F., Di Giunta G., Figueiredo C. P., Rodrigues E. B., Grumman A. Jr., Medeiros R., Calixto J. B., Exp. Eye Res., 84, 553-560 (2007).
34. De Rochemonteix-Galve B., Marchat-αmoruso B., Dayer J. M., Ry-lander R., Infect. Immun., 59, 3646-3650 (1991).
35. Adcock I. M., Caramori G., Chung K. F., Lancet, 372, 1073-1087 (2008).